Potential Meilleure Health International Industry Group Limited (HKG:2327) shareholders may wish to note that the Executive Co-Chairman of the Board, Xuzhou Zhou, recently bought HK$3.5m worth of stock, paying HK$0.29 for each share. However, it only increased shareholding by a small percentage, and it wasn't a huge purchase by absolute value, either.

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

Meilleure Health International Industry Group Insider Transactions Over The Last Year

In fact, the recent purchase by Xuzhou Zhou was the biggest purchase of Meilleure Health International Industry Group shares made by an insider individual in the last twelve months, according to our records. So it's clear an insider wanted to buy, at around the current price, which is HK$0.30. That means they have been optimistic about the company in the past, though they may have changed their mind. While we always like to see insider buying, it's less meaningful if the purchases were made at much lower prices, as the opportunity they saw may have passed. Happily, the Meilleure Health International Industry Group insider decided to buy shares at close to current prices. Xuzhou Zhou was the only individual insider to buy during the last year.

Xuzhou Zhou purchased 116.06m shares over the year. The average price per share was HK$0.25. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

See our latest analysis for Meilleure Health International Industry Group

Meilleure Health International Industry Group is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.

Insider Ownership Of Meilleure Health International Industry Group

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Meilleure Health International Industry Group insiders own 63% of the company, currently worth about HK$764m based on the recent share price. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.

What Might The Insider Transactions At Meilleure Health International Industry Group Tell Us?

The recent insider purchase is heartening. And the longer term insider transactions also give us confidence. Once you factor in the high insider ownership, it certainly seems like insiders are positive about Meilleure Health International Industry Group. One for the watchlist, at least! In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Meilleure Health International Industry Group. You'd be interested to know, that we found 1 warning sign for Meilleure Health International Industry Group and we suggest you have a look.

Of course Meilleure Health International Industry Group may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.